United States was ENvue Medical’s largest region in fiscal 2025, bringing in $2.51M of $2.55M (98%).
| Geography | FY 2015 | FY 2016 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $2.16M | $2.45M | $2.51M | ||||||
| United Kingdom | — | — | — | ||||||
| Europe | $101.00K | $17.00K | $8.00K | ||||||
| European Union (Excluding United Kingdom) | — | — | — | ||||||
| Australia/New Zealand | — | $41.00K | $20.00K | ||||||
| Other | — | — | — | ||||||
| Other Country | — | $50.00K | $15.00K | ||||||
| Israel | $1.00K | — | — | ||||||
| Australia | $19.00K | — | — | ||||||
| India | — | — | — | ||||||
| Total | $2.28M | $2.56M | $2.55M |
ENvue Medical brought in $2.55M from its four regions in fiscal 2025, the year ended December 31, 2025. That was down 0.2% from $2.56M in fiscal 2024. United States was the largest at $2.51M (98.3%), ahead of Australia/New Zealand at $20.00K (0.8%) and Other Country at $15.00K (0.6%). The remaining region, Europe, brought in $8.00K.
ENvue Medical began breaking out Australia/New Zealand in fiscal 2024, when it brought in $41.00K. ENvue Medical stopped reporting Australia ($19.00K in fiscal 2023) and Israel ($1.00K in fiscal 2023) as separate regions.
Nano Vibronix was ENvue Medical’s largest segment in fiscal 2025, bringing in $1.86M of $2.55M (73%).
| Segment | FY 2024 | FY 2025 |
|---|---|---|
| Nano Vibronix | $2.56M | $1.86M |
| Envue | — | $696.00K |
| Total | $2.56M | $2.55M |
ENvue Medical brought in $2.55M from its two segments in fiscal 2025, the year ended December 31, 2025. ENvue Medical regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $2.56M. Nano Vibronix was the largest at $1.86M (72.7%), ahead of Envue at $696.00K (27.3%).
ENvue Medical began breaking out Envue in fiscal 2025, when it brought in $696.00K.
ENvue Medical (FEED) reports its revenue by geography and by segment. In fiscal 2025, United States was its largest region, bringing in $2.51M (98.3% of the total), followed by Australia/New Zealand at $20.00K (0.8%).
United States was ENvue Medical's largest region in fiscal 2025, bringing in $2.51M, or 98.3% of the $2.55M total across its four regions.
Nano Vibronix was ENvue Medical's largest segment in fiscal 2025, bringing in $1.86M, or 72.7% of the $2.55M total across its two segments.
Every figure comes from ENvue Medical's annual financial filings, as reported. Each line keeps the name ENvue Medical gives it, and years follow its fiscal calendar.
ENvue Medical's revenue by geography goes back to fiscal 2015, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.